« BACK  |  PRINT

RS

MEMBER DIARY

Obamacare and the Future of Drug Innovation

Download Podcast | iTunes | Podcast Feed

Throughout the month of December, Coffee and Markets will be looking back at the most significant stories of 2010 with recap interviews from leading thinkers. In today’s edition, Ben Domenech interviews Avik Roy, a health care analyst on Wall Street and author of The Apothecary blog, about how Obamacare effects pharmaceutical innovation.

We’re brought to you as always by BigGovernment and Stephen Clouse and Associates. You can find our iTunes feed at CoffeeandMarkets.com. If you’d like to email us, you can do so at coffee[at]newledger.com. We hope you enjoy the show.

Related Links:

Pitts: Keeping the U.S. Lead in Medical Innovation
Podcast: The Market Case for Health Care
Roy: Why is the Pharma Pipeline Clogged?
Roy: The Fiscal Commission on Health Care Reform

Follow Ben Domenech on Twitter
Follow Avik Roy on Twitter

COMMENTS

  • tjpeco

    At a CRO – we are the “outsourced” drug research division of the pharma companies. I’ve been doing this for close to 10 years now. I can tell you that the ONLY reason for my job, or my company to exist in the first place, is because of FDA red tape. There is no other reason. My personal billable rate is $150/hour – and I’ll spend no less than 300 hours on any individual project – and I’m only a single cog in a bigger machine – a machine that has billable rates much higher than mine. Whats even more pathetic is that we do it cheaper than the pharmas themselves can do it themselves for.

    So the next time someone tells you that government doesn’t create jobs – I laugh and say “the only reason I pull in a paycheck is because the FDA makes pharmaceutical companies’ existence miserable” (They make my life miserable too)

  • DefendUSA

    Innovation on any technical front will cease to exist because those who are smart enough to make the most of the intellectual capital for means of producing will only go where the risks still result in some kind of profit. They will have no choice.

    The doctors are already doing it…we are headed in to a swirling toilet bowl.